| For: | Bakulin I, Pasechnikov V, Varlamicheva A, Sannikova I. NS3 protease inhibitors for treatment of chronic hepatitis C: Efficacy and safety. World J Hepatol 2014; 6(5): 326-339 [PMID: 24868326 DOI: 10.4254/wjh.v6.i5.326] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v6/i5/326.htm |
| Number | Citing Articles |
| 1 |
Hui-Chun Li, Shih-Yen Lo. Hepatitis C virus: Virology, diagnosis and treatment. World Journal of Hepatology 2015; 7(10): 1377-1389 doi: 10.4254/wjh.v7.i10.1377
|
| 2 |
Nancy W. Withers. Handbook of Consultation-Liaison Psychiatry. 2015; doi: 10.1007/978-3-319-11005-9_30
|
| 3 |
Elizabeth Yihui Ng, Ying Ru Loh, Yan Li, Qingxin Li, CongBao Kang. Expression, purification of Zika virus membrane protein-NS2B in detergent micelles for NMR studies. Protein Expression and Purification 2019; 154 doi: 10.1016/j.pep.2018.09.013
|
| 4 |
Zafirah Liyana Abdullah, Hui-Yee Chee, Rohana Yusof, Fazlin Mohd Fauzi. Finding Lead Compounds for Dengue Antivirals from a Collection of Old Drugs through In Silico Target Prediction and Subsequent In Vitro Validation. ACS Omega 2023; 8(36) doi: 10.1021/acsomega.3c02607
|
| 5 |
Keiko I. Greenberg, Mark A. Perazella, Mohamed G. Atta. HIVandHCVMedications in End‐Stage Renal Disease. Seminars in Dialysis 2015; 28(4) doi: 10.1111/sdi.12367
|
| 6 |
Eman Mahmoud, Mohd Rehan. Computational Exploration of Flavonoids as HCV NS3/4A Protease Inhibitors: Advancing Antiviral Therapies to Mitigate Liver Cancer Risk. Current Pharmaceutical Design 2026; 32(25) doi: 10.2174/0113816128386884250904063752
|
| 7 |
V. L. Korobka, E. S. Pak, V. D. Pasechnikov, M. Yu. Kostrykin. Compensation of HCV-associated decompensated cirrhosis treated with modern direct-acting antiviral agents. Dokazatel'naya gastroenterologiya 2019; 8(4-5) doi: 10.17116/dokgastro2019804-05111
|
| 8 |
Palak K. Parikh, Nisha H. Parikh, Mahalakshmi B, Ketan M. Ranch, Sai H.S. Boddu, Jayachandra Babu R, Amit K. Tiwari. Developments in small molecule antiviral drugs against hepatitis B and C viruses: FDA approved therapies and new drugs in clinical trials. Arabian Journal of Chemistry 2023; 16(8) doi: 10.1016/j.arabjc.2023.105013
|